Mode
Home
Research
Clinical Trials Drug Pipeline Weekly Digests
Reference
Conditions Medications
Community
Questions
Text Size
Log in / Sign up
Home › Medications › nifedipine

nifedipine

2 published articles · Updated continuously

Clinical Trial Landscape

Clinical Trials of nifedipine

9 trials tracked of nifedipine: 3 in phase 3 or 4 and 1 with published results. The most-cited published study has 67 citations.

9Trials tracked
3Phase 3 & 4
0Recruiting
1With published results
Phase distribution
Phase 4 2 Phase 3 1 Phase 2 2 Other / NA 4
  1. Phase 3 Nifedipine for Acute Tocolysis of Preterm Labor Completed · 67 cited
  2. Phase 4 Response to Anti-hypertensives in Pregnant and Postpartum Patients Completed
  3. Phase 4 Effectiveness of Valsartan/Amlodipine (EXforge®) and Nifedipine treAtment coMparison in Treating Chinese Hypertensive Patients Completed
  4. Phase 2 Indomethacin Versus Nifedipine for Preterm Labor Tocolysis Completed
  5. Phase 2 Effects Of Sitaxsentan On Proteinuria, 24-Hour Blood Pressure, And Arterial Stiffness In Chronic Kidney Disease Subjects Completed
  6. N/A Comparison of Nifedipine Versus Indomethacin for Acute Preterm Labor Completed
Show 3 more trials
  1. N/A Magnesium Sulfate Versus Nifedipine for the Acute Tocolysis of Preterm Labor: A Prospective, Randomized Trial Completed
  2. N/A Tocolysis for Preterm Labor Completed
  3. N/A Oral Nifedipine Versus Oral Labetalol Completed

Showing the 9 most-cited and recently-updated of 9 trials. Browse the full registry →

Trial data sourced from ClinicalTrials.gov. Counts describe the research landscape and are not a treatment recommendation. Informational only — not medical advice.

HCP Mode — summaries include clinical detail, trial data, and statistical outcomes.
Patient Mode — summaries use plain language, avoiding clinical jargon.
Calcium channel blockers cause rare pulmonary toxicity at standard doses but increase risk during overdose
Drug Pipeline Sys. Review
Calcium channel blockers cause rare pulmonary toxicity at standard doses but increase risk during overdose Calcium Channel Blockers Linked to Rare Lung Issues in Overdose
This systematic review examines the incidence and mechanisms of pulmonary toxicity associated with calcium channel blockers (CCBs). While pu…
While calcium channel blockers are generally well-tolerated, some reports link specific types to rare cases of lung fluid buildup.
Frontiers Sep 22, 2026
Rate of drug concentration rise alters hemodynamic responses and mortality risk in coronary heart disease patients
Drug Pipeline Meta-analysis
Rate of drug concentration rise alters hemodynamic responses and mortality risk in coronary heart disease patients New analysis shows how fast drug levels change affects patient safety outcomes
This narrative review and theoretical framework synthesizes evidence on rate-dependent pharmacology. It highlights divergent hemodynamic res…
This review explains that how quickly medicine levels rise in the body matters for safety. Fast changes can cause more harm than slow ones, …
medRxiv Jun 4, 2026